This Telehealth System Could Be Scaled Up Statewide To Treat Opioid Use Disorder
This Model Is Cheaper And Easier To Use Than The ER, LDI Fellow Argues In New Op-Ed
Opioid Epidemic
Blog Post
Simplicity in Opioid Disposal Can Reduce Risk
A Mailed, At-Home Opioid Disposal Kit Improved the Likelihood of Patient-Reported Opioid Disposal Following Surgery
Print:
The opioid epidemic continues to take a heavy toll on the nation. One upstream strategy to help reverse it focuses on the safe disposal of prescribed opioids left over after a prescription is no longer needed. Accounting for up to 70% of opioids prescribed following common surgeries, these pills sit in cabinets or on countertops, posing a potential risk to the patient, their family or loved ones, and the broader community. Extra opioids can contribute to prolonged use, future misuse, and community diversion, all of which contribute to the overarching epidemic.
We examined the potential of mailing a simple, low-cost ($1.50/patient), at-home opioid disposal kit to improve opioid disposal rates following common surgeries. The DisposeRx kits are roughly the size of a ketchup packet and contain a powder that renders medications unusable when mixed with water according to directions.
As we recently reported in JAMA Network Open, we conducted a randomized controlled trial comparing mailed disposal kits to usual care. Usual care comprised a text message reminder to dispose of leftover opioids accompanied by a link to nearby disposal “take-back” sites.
We followed the 302 patients in the trial by tracking the data that they entered—on levels of pain, opioid use, and opioid disposal—into an automated post-operative text messaging program developed by our team. We found that while 42.7% of usual care patients reported disposal, 60.0% of patients mailed an at-home kit reported disposal, resulting in the disposal of approximately 500 extra pills.
As clinicians and health systems attempt to “right-size” opioid prescribing to adequately address pain while not overprescribing, efforts that encourage opioid disposal are equally important. Current disposal options all have drawbacks that deter disposal:
- “Opioid drop boxes” and secure facilities—often at pharmacies—offer patients a place where they can physically bring back their opioids. However, this requires patients to remember to dispose of their unused opioids, find a site, and travel to the site.
- Mail-back programs—such as the program that the FDA is exploring—allow patients to mail opioids from their homes in prelabeled packaging. These programs seem promising but pose potential risks for diversion.
- Flushing unused medications or throwing them in the trash can also be used for disposal. The FDA has posted information on using the toilet to flush medication on its website, however, flushing medications or disposing of them in the trash raises environmental concerns.
Our findings suggest that the mailed at-home disposal kits provide a simple method that could help motivate patients to dispose of unused opioids following surgery. Timing the kits’ arrival may also play a key role in their success. Our prior work showed that following common surgeries, patients often finish using opioids around post-operative day four, and kits arriving at this point can act as a convenient disposal reminder.
As the FDA considers mail-back programs and other potential new avenues for disposal, our work highlights the need to make the “right decision the easy decision” for patients.
The study, Effect of Mailing an At-Home Disposal Kit on Unused Opioid Disposal After Surgery: A Randomized Clinical Trial, was published in the May 6, 2022, issue of JAMA Network Open. Authors include Anish K. Agarwal, Daniel Lee, Zarina Ali, Yaxin Wu, Mary Cognilio, Tanya Uritsky, M. Kit Delgado.
Author
Anish Argarwal, MD, MPH
Assistant Professor, Emergency Medicine, Perelman School of Medicine
More on the Opioid Epidemic
Fears of Family Separation Deter Parents With Substance Use Disorder From Getting Needed Care
Policymakers Should Consider Reporting and Planning Procedures That Do Not Involve Child Protective Services
Naloxone Access Improved in New York City in High Overdose Areas, But Gaps Remain Across the Five Boroughs
New Maps From LDI Researchers Show Progress in Locating Programs Where the Need Is Greatest
Penn’s Jeanmarie Perrone Testifies Before Senate Committee on Finance
Xylazine and Telehealth Rule Exemptions Dominate Hearing
Testimony: Front Lines of the Fentanyl Crisis: Supporting Communities and Combating Addiction through Prevention and Treatment
Delivered to the United States Senate Committee on Finance
Comment: Opportunities to Improve Substance Use Disorder Care in the Federal Health Programs
Submitted to U.S. Senate Committee on Finance